GlaxoSmithKline | GSK - Operating Expenses

Stock Price
2,209.50
Daily Change
8.50 0.39%
Monthly
20.84%
Yearly
50.61%
Q1 Forecast
2,168.74

GlaxoSmithKline reported GBP7.18B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
AbbVie USD 10.81B 13.45B Dec/2025
Alcon AG USD 2.28B 67M Sep/2025
Almirall EUR 517.4M 32K Dec/2025
Amgen USD 5.9B 773M Dec/2025
argenx SE USD 776.99M 32.87M Sep/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
Bayer EUR 10.2B 523M Sep/2025
Biogen USD 1.88B 81.4M Sep/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
Eli Lilly USD 10.31B 1.09B Dec/2025
Fresenius EUR 4.91B 110M Sep/2025
Fresenius Medical Care EUR 4.41B 27.91M Dec/2025
Galapagos EUR 112.83M 9.48M Sep/2025
Genmab DKK 565M 38M Jun/2025
Gilead Sciences USD 4.96B 707M Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
Glaxosmithkline GBP 7.77B 2.22B Sep/2025
GRIFOLS EUR 1.51B 28.3M Sep/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.11B 117M Sep/2025
Merck USD 10.16B 558M Dec/2025
Novartis USD 9.86B 115M Sep/2025
Novo Nordisk DKK 46.76B 3.99B Dec/2025
Orion EUR 367.1M 64.9M Dec/2025
Pfizer USD 12.91B 79.89B Dec/2025
Philips EUR 4.38B 405M Dec/2025
Recordati EUR 384.01M 82.67M Dec/2025
Regeneron Pharmaceuticals USD 2.99B 27.97B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
Smith & Nephew USD 2.52B 84M Dec/2025
UCB EUR 2.36B 108M Dec/2024